Effect of Vırtual Realıty Glasses on Mıld Cognıtıve Impaırment in Elderly

NCT06735352 | Completed

• 1 other identifier: RCS15102024
• Study Type: interventional
• Target: 12
• Locations: 1 country
• Sites: 1

Brief Summary

This study was conducted in a randomized controlled manner to investigate the effect of VR glasses on mild cognitive impairment in the elderly. The main questions the study aimed to answer are:

• Will VR improve mild cognitive impairment in the elderly? The researchers used a control group to compare the effect of VR on mild cognitive impairment. Participants:
• Before starting the study, the elderly were given the necessary forms and information.
• The elderly were shown virtual reality videos with VR glasses 3 days a week for 4 weeks.
• The control group did not watch any videos, and the post-test forms were filled out again for both groups at the end of 4 weeks.

Conditions

Mild Cognitive Impairment (MCI)

Keywords

elderly; virtual reality; mild cognitive impairment; nursing

Outcome Measures

Primary Outcomes (3)

• Elderly Information Form

  The study includes questions to determine the age, gender, marital status, education level and chronic disease status of elderly individuals.

  4 week

• Mini-Mental State Examination

  The MMSE, which provides assessment of cognitive status, was developed by Folstein and colleagues in 1975 and is the most commonly used and easily administered test in dementia screening (Folstein, 1975). Its validity and reliability in the diagnosis of mild dementia for the Turkish population was performed by Güngen and colleagues (Güngen 2002). The mini mental test is grouped under five main headings: orientation (10 points), recording memory (3 points), attention and calculation (5 points), recall (3 points) and language (9 points). The scale is evaluated out of a total of 30 points and has two different types for the educated and the uneducated. Traditionally, scores between 24 and 30 are considered normal. A score below 24 indicates cognitive impairment. A score between 18-23 points is considered mild dementia, 12-17 points is considered moderate dementia and 12 points below is considered severe dementia.

  4 week

• Montreal Cognitive Assessment Scale

  It is a screening scale developed specifically to evaluate the early stages of cognitive impairment. The scale evaluates attention and concentration, executive functions, memory, language, visual and spatial skills, abstract thinking, calculation and orientation functions. The test takes approximately 10 minutes. The visual structuring skills test is worth 5 points, the attention test is worth 6 points, the language (naming) test is worth 6 points, the abstract thinking test is worth 2 points, the delayed recall is worth 5 points and the orientation test is worth 6 points. Patients with 21 points and above out of 30 points are considered cognitively normal.

  4 week

Study Arms (2)

Control Group

NO INTERVENTION

No intervention was made to the elderly in this group.

virtual reality group

EXPERIMENTAL

Evaluated the effect of using virtual reality in elderly people with mild cognitive impairment.

Other: virtual reality intervention

Interventions

virtual reality intervention OTHER

Evaluated the effect of virtual reality use in elderly people with mild cognitive impairment compared to a control group.

virtual reality group

Eligibility Criteria

• Age: 65 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• The study included elderly individuals who were over the age of 65,
• Diagnosed with MCI by a neurologist,
• Having a Standard Mini-Mental Statement (MMSE) score between 18 and 23,
• Having a Montreal Cognitive Assessment Scale (MOCA) score below 21,
• Able to communicate verbally,
• Agreeing to participate in the study.

You may not qualify if:

• The study excluded those with a history of stroke or epilepsy,
• Those with other suspected degenerative diseases or diagnosed severe psychiatric illnesses,
• Those with head trauma, thyroid disorders or other medical abnormalities that could impair cognitive function.

Sponsors & Collaborators

• Karadeniz Technical University: lead
• The Scientific and Technological Research Council of Turkey: collaborator

Study Sites (1)

Bayburt State Hospital

Bayburt, Centre, 69000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition Disorders; Neurocognitive Disorders; Mental Disorders

Study Officials

• Buket DAŞTAN, Ph.D

  Karadeniz Tecnic University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, OUTCOMES ASSESSOR
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assist. Prof. Dr.

Study Record Dates

• First Submitted: December 5, 2024
• First Posted: December 16, 2024
• Study Start: December 1, 2023
• Primary Completion: August 15, 2024
• Study Completion: October 15, 2024
• Last Updated: December 16, 2024

Record last verified: 2024-12

Locations

TU (1)